New technologies are transforming the global health-care delivery system. Advancements provide opportunities but could also pose risks to patient outcomes. What regulatory guardrails are needed for emerging technologies, such as artificial intelligence, to ensure that safety and health equity are at the center of new developments? Experts share policy proposals under review, the programs that have transformed patient care, and the disruptors at the forefront of the health-care-technology revolution.
Atlantic writers Ross Anderson and Vann R. Newkirk II, alongside CBS correspondent Christina Ruffini, talk with Xavier Becerra, Hugh Herr, Ivor Braden Horn, Mike Madsen, Debra Mathews, Andrea Ducas, Mary R. Grealy*, Dennis Hancock*, and Robert Stone*.
*This session is produced by our underwriter and is independent (cdn.theatlanti...) of The Atlantic’s editorial staff.. Underwritten by Pfizer and City of Hope.
18 сен 2024
